Image
15.03.2022
Easing the burden for people with diabetes
Is there anything healthcare professionals can do differently to help people with diabetes who are findin...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more